Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 4,181 $ 29,972
Restricted cash 0 203
Accounts receivable, less allowance of $2,164 and $2,154 as of December 31, 2022 and 2021, respectively 5,841 4,238
Inventory 15,884 12,929
Prepaid expenses and other current assets 3,053 2,012
Total current assets 28,959 49,354
Property, plant, and equipment, net 4,278 1,067
Goodwill 2,926 2,926
Right of use asset 1,768 1,717
Other assets 255 220
Total assets 38,186 55,284
Current liabilities:    
Accounts payable 5,786 3,309
Accrued liabilities 9,210 8,276
Deferred revenue, current portion 2,111 2,259
Current portion of term loans, net of discount 700 0
Total current liabilities 17,807 13,844
Deferred revenue 418 329
Warranty accrual 360 521
Non current term loans, net of discount 13,091 13,603
Non current operating lease liability 1,259 1,449
Other liabilities 362 330
Total liabilities 33,297 30,076
Commitments and contingencies —Note 7
Stockholders' equity:    
Series F Preferred stock, par value $0.001 per share; 18 shares authorized, 0 and 0 shares issued and outstanding as of December 31, 2022 and 2021, respectively 0 34
Common stock, par value $0.001 per share; 180,000 shares authorized, 7,723 and 153,721 shares issued and 7,721 and 153,676 shares outstanding as of December 31, 2022 and 2021, respectively 8 6
Additional paid-in capital 301,782 293,325
Accumulated other comprehensive loss (733) (623)
Accumulated deficit (296,168) (267,534)
Total stockholders' equity 4,889 25,208
Total liabilities, redeemable preferred stock and stockholders' equity $ 38,186 $ 55,284